Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.86% | 5.15% | -15.94% | 21.53% | -0.06% |
| Total Depreciation and Amortization | 0.73% | 11.58% | 0.82% | 10.14% | -3.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,040.00% | 93.83% | -125.47% | 381.82% | 137.08% |
| Change in Net Operating Assets | 89.88% | 61.78% | -348.77% | 529.81% | 85.67% |
| Cash from Operations | 20.00% | 78.27% | -65.52% | 54.40% | 60.04% |
| Capital Expenditure | 2.89% | -19.68% | 19.14% | -15.10% | -37.41% |
| Sale of Property, Plant, and Equipment | -75.00% | -55.56% | -66.67% | 575.00% | 300.00% |
| Cash Acquisitions | -- | 100.00% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -207.70% | 119.42% | -79.08% | 323.25% | 6,180.00% |
| Cash from Investing | -146.95% | 101.83% | -1,105.72% | 121.61% | -1,331.60% |
| Total Debt Issued | -- | -100.00% | 14.39% | 349.22% | -- |
| Total Debt Repaid | -184.58% | 72.45% | -9.88% | -115.24% | 24.14% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | 66.67% | -8,008.11% | 96.16% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.57% | -8.02% | 0.00% | 0.61% | -0.62% |
| Other Financing Activities | 3,214.29% | -117.50% | -56.04% | 2,375.00% | 90.48% |
| Cash from Financing | 32.34% | -243.73% | -69.00% | 657.91% | 36.23% |
| Foreign Exchange rate Adjustments | -112.24% | 25.64% | 1,400.00% | 92.00% | -124.12% |
| Miscellaneous Cash Flow Adjustments | -- | 100.00% | -- | -- | -- |
| Net Change in Cash | 71.32% | 112.37% | -183.87% | 403.55% | -701.39% |